You are viewing the site in preview mode
Skip to main content
|
Predictor
|
Level
|
No treatment interruption n (%)
|
≥90 day treatment interruption n (%)
|
|---|
|
n = 30,472
|
n = 10,162
|
|---|
|
Sex
|
Female
|
14,785 (48.5)
|
4835 (47.6)
|
|
Male
|
15,675 (51.4)
|
5326 (52.4)
|
|
Age (years)
|
<20
|
1601 (5.3)
|
481 (4.7)
|
|
20–39
|
18,408 (60.4)
|
6217 (61.2)
|
|
40–59
|
7181 (23.6)
|
1877 (18.5)
|
|
60+
|
318 (1.0)
|
67 (0.7)
|
|
WHO stage at ART initiation
|
1
|
2704 (8.9)
|
980 (9.6)
|
|
2
|
2862 (9.4)
|
1063 (10.5)
|
|
3
|
15,317 (50.3)
|
5083 (50.0)
|
|
4
|
9001 (29.5)
|
2825 (27.8)
|
|
CD4 count at ART initiation (cells/μL)
|
<200
|
13,182 (45.3)
|
3864 (38.0)
|
|
200–350
|
4000 (13.1)
|
1348 (13.3)
|
|
>350
|
1304 (4.3)
|
450 (4.4)
|
|
Marital status
|
Not married
|
13,517 (44.4)
|
4613 (45.6)
|
|
Married
|
15,945 (52.3)
|
5343 (52.6)
|
|
Region
|
Africa
|
6189 (20.3)
|
1996 (19.6)
|
|
Asia
|
24,281 (79.7)
|
8166 (80.4)
|
- Missing data <5 % for all apart from; age (9.7 % no uTI, 15.0 % uTI), and CD4 count (37.3 % no uTI, 44.3 % uTI)
-
uTI unstructured treatment interruption
